Pieris Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Property and Equipment, net

Property and Equipment, net

12 Months Ended

Dec. 31, 2014

Property, Plant and Equipment [Abstract]

5.	Property and Equipment, net

Property and equipment are summarized as follows:


	December 31,
	2014			2013
Leasehold improvements	$	50,791		$	57,779
Laboratory equipment		3,840,368			4,093,704
Office and computer equipment		343,835			389,368

Property and equipment at cost		4,234,994			4,540,852

Accumulated depreciation		(2,182,773	)		(2,103,175	)

Property and equipment, net	$	2,052,221		$	2,437,677

Accumulated depreciation for each asset group is summarized as follows:


	Years ended December 31,
	2014		2013
Leasehold improvements	$	41,606	$	37,904
Laboratory equipment		1,886,807		1,845,098
Office and computer equipment		254,360		220,172

Total accumulated depreciation	$	2,182,773	$	2,103,175

Depreciation expense was $366,979 and $384,677 for the years ended December 31, 2014 and 2013, respectively. There were no other changes in accumulated depreciation other than foreign currency impact.